1,324 results on '"Pae, Chi-Un"'
Search Results
102. Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice
103. Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
104. Validation of the Korean version of the Generalized Anxiety Disorder 7 self‐rating Scale
105. The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis
106. ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
107. Taking a Responsibility for Future Progression of Clinical Psychopharmacology and Neuroscience
108. Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
109. Contribution of Personality Traits, Psychological Factors, and Health-Related Quality of Life to Medication Adherence in Patients with Rheumatoid Arthritis
110. Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
111. Quetiapine XR: Current status for the treatment of major depressive disorder
112. Effect of quetiapine-XR on irritable bowel syndrome
113. Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly
114. Accelerating response to antidepressant treatment in depression: A possible role for atypical antipsychotics
115. Follow-up study of suicide attempters who were given crisis intervention during hospital stay: Pilot study
116. Risperidone in the treatment of mixed state bipolar patients: Results from a 24-week, multicenter, open-label study in Korea
117. Rash and lamotrigine in bipolar patients
118. Clinical trials report
119. Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive-compulsive disorder
120. Influence of TAAR6 polymorphisms on response to aripiprazole
121. History of depressive and/or anxiety disorders as a predictor of treatment response: A post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia
122. Thyroid hormones affect recovery from depression during antidepressant treatment
123. Supersensitivity psychosis and aripiprazole tapering
124. Pregabalin augmentation to antidepressants in patients with major depressive disorder
125. Safety and antipsychotic efficacy of “forced” intramuscular olanzapine over five days: A case report
126. Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms
127. Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
128. Association of the serotonin transporter gene polymorphism with Korean male alcoholics
129. fMRI investigation on cue-induced smoking craving
130. Profile of paliperidone extended release: review of efficacy and safety data
131. Effectiveness of carbamazepine for benzodiazepine-resistant impulsive aggression in a patient with frontal infarctions
132. A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?
133. Comments on “Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder”
134. Comments on “Addition of lamotrigine to valproic acid: A successful outcome in a case of rapid-cycling bipolar affective disorder”
135. Tardive dystonic symptoms associated with aripiprazole treatment
136. Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder☆: A randomized, open-label, 12-week, parallel-group trial
137. Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder
138. Psychometric properties of the Korean version of the Short Post-Traumatic Stress Disorder Rating Interview (K-SPRINT)
139. Triple Reuptake Inhibitors: The Next Generation of Antidepressants
140. Monocyte chemoattractant protein-1 (MCP1) may play a role in depression
141. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion
142. Birth order and sibling sex ratio in homosexual transsexual South Korean men: Effects of the male-preference stopping rule
143. Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open-label, prospective, multi-center trial in Korea
144. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder
145. Selegiline transdermal system: Current awareness and promise
146. Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder
147. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder
148. Heat-shock protein-70 genes and response to antidepressants in major depression
149. Comments on “Low plasma BDNF is associated with suicidal behavior in major depression” by Y.K. Kim et al. Progress in Neuropsychopharmacology and Biological Psychiatry 2006 Aug 9; [Epub ahead of print]
150. Paroxetine: current status in psychiatry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.